Literature DB >> 9598774

An in-vitro study of carbapenem-induced morphological changes and endotoxin release in clinical isolates of gram-negative bacilli.

T Horii1, M Kobayashi, K Sato, S Ichiyama, M Ohta.   

Abstract

One hundred clinical isolates, including Escherichia coli, Serratia marcescens, Klebsiella pneumoniae, Pseudomonas aeruginosa, Proteus vulgaris and Proteus mirabilis, were exposed to carbapenems (imipenem, panipenem, meropenem and biapenem) at 0.5 x MIC for 3 h, then their morphology was examined and endotoxin release determined. Ceftazidime, which induces filament formation, was used as a control. Scanning electron microscopy showed that these carbapenems induced formation of spherical or ovoid cells, except for P. aeruginosa treated with meropenem and biapenem; these latter cells had a 'bulge' midway along them and we have termed them 'oval-centred'. There was a relationship between morphology and the amount of endotoxin released following exposure to carbapenems or ceftazidime. Of all the species investigated, P. aeruginosa showed the most variable morphological changes. P. aeruginosa exposed to biapenem were longer oval-centred in shape, and released significantly more endotoxin than those exposed to imipenem, panipenem (spherical) or meropenem (shorter oval-centred cells) (P=0.030, 0.017 and 0.002, respectively). In all strains except P. aeruginosa, carbapenems induced significantly less endotoxin release than ceftazidime (P < 0.05).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9598774     DOI: 10.1093/jac/41.4.435

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  15 in total

Review 1.  Comparative pharmacokinetics of the carbapenems: clinical implications.

Authors:  J W Mouton; D J Touzw; A M Horrevorts; A A Vinks
Journal:  Clin Pharmacokinet       Date:  2000-09       Impact factor: 6.447

2.  Responses of wild-type and resistant strains of the hyperthermophilic bacterium Thermotoga maritima to chloramphenicol challenge.

Authors:  Clemente I Montero; Matthew R Johnson; Chung-Jung Chou; Shannon B Conners; Sarah G Geouge; Sabrina Tachdjian; Jason D Nichols; Robert M Kelly
Journal:  Appl Environ Microbiol       Date:  2007-06-08       Impact factor: 4.792

Review 3.  Meropenem: a review of its use in patients in intensive care.

Authors:  M Hurst; H M Lamb
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

Review 4.  Morphological and ultrastructural changes in bacterial cells as an indicator of antibacterial mechanism of action.

Authors:  T P Tim Cushnie; Noëlle H O'Driscoll; Andrew J Lamb
Journal:  Cell Mol Life Sci       Date:  2016-07-08       Impact factor: 9.261

5.  Rapid conversion of Pseudomonas aeruginosa to a spherical cell morphotype facilitates tolerance to carbapenems and penicillins but increases susceptibility to antimicrobial peptides.

Authors:  Leigh G Monahan; Lynne Turnbull; Sarah R Osvath; Debra Birch; Ian G Charles; Cynthia B Whitchurch
Journal:  Antimicrob Agents Chemother       Date:  2014-01-13       Impact factor: 5.191

6.  Development of MAST: A Microscopy-Based Antimicrobial Susceptibility Testing Platform.

Authors:  Kenneth P Smith; David L Richmond; Thea Brennan-Krohn; Hunter L Elliott; James E Kirby
Journal:  SLAS Technol       Date:  2017-08-24       Impact factor: 3.047

7.  Comparative effects of carbapenems on bacterial load and host immune response in a Klebsiella pneumoniae murine pneumonia model.

Authors:  Jamese J Hilliard; John L Melton; LeRoy Hall; Darren Abbanat; Jeffrey Fernandez; Christine K Ward; Rachel A Bunting; A Barron; A Simon Lynch; Robert K Flamm
Journal:  Antimicrob Agents Chemother       Date:  2010-12-06       Impact factor: 5.191

8.  Aminoglycoside Concentrations Required for Synergy with Carbapenems against Pseudomonas aeruginosa Determined via Mechanistic Studies and Modeling.

Authors:  Rajbharan Yadav; Jürgen B Bulitta; Elena K Schneider; Beom Soo Shin; Tony Velkov; Roger L Nation; Cornelia B Landersdorfer
Journal:  Antimicrob Agents Chemother       Date:  2017-11-22       Impact factor: 5.191

9.  Individual or Combined Effects of Meropenem, Imipenem, Sulbactam, Colistin, and Tigecycline on Biofilm-Embedded Acinetobacter baumannii and Biofilm Architecture.

Authors:  Yung-Chih Wang; Shu-Chen Kuo; Ya-Sung Yang; Yi-Tzu Lee; Chun-Hsiang Chiu; Ming-Fen Chuang; Jung-Chung Lin; Feng-Yee Chang; Te-Li Chen
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

10.  High-Content Imaging to Phenotype Antimicrobial Effects on Individual Bacteria at Scale.

Authors:  Sushmita Sridhar; Sally Forrest; Ben Warne; Mailis Maes; Stephen Baker; Gordon Dougan; Josefin Bartholdson Scott
Journal:  mSystems       Date:  2021-05-18       Impact factor: 6.496

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.